Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 2/20 | 0.40 |
| ▸ | PGK2 | P07205 | 2/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6044987 | 0.80 | PGK1 (0.38) | PGK1PGK2 | |
| SCHEMBL4544106 | 0.80 | PGK1 (0.40) | PGK1PGK2ADORA2A | |
| SCHEMBL4544102 | 0.79 | PGK1 (0.62) | PGK1PGK2 | |
| SCHEMBL6045205 | 0.69 | PGK1 (0.31) | PGK1PGK2 | |
| SCHEMBL6044980 | 0.65 | PGK1 (0.38) | PGK1PGK2 | |
| SCHEMBL4544109 | 0.65 | PGK1 (0.41) | PGK1PGK2 | |
| SCHEMBL6044969 | 0.65 | PGK1 (0.60) | PGK1PGK2 | |
| SCHEMBL6044952 | 0.60 | PGK1 (0.53) | PGK1PGK2 | |
| SCHEMBL17489025 | 0.60 | PGK1 (0.53) | PGK1PGK2 | |
| SCHEMBL16277737 | 0.59 | PGK1 (0.67) | PGK1PGK2ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778699-A4 | TARGETING CHELANTS AND CHELATES | DOW GLOBAL TECHNOLOGIES INC (US) | 2009-02-25 | — | — | EP | disclosed |
| EP-1778699-A2 | TARGETING CHELANTS AND CHELATES | Dow Gloval Technologies Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| US-20060210479-A1 | Targeting chelants and chelates | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-21 | — | — | US | disclosed |
| WO-2006020779-A2 | TARGETING CHELANTS AND CHELATES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060210479-A1 | Targeting chelants and chelates | CLTC, CALCOCO2, TFRC | PGK1 2785/4885PGK2 2466/4885ADORA2A 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.